MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Laryngeal clinical biomarkers in atypical Parkinsonism – results from an international multicenter study

    F. Gandor, A. Vogel, L. Berger, D. Gruber, I. Claus, P. Corelli, G. Giannini, N. Madetko-Alster, G. Höglinger, M. Klietz, C. Schrader, B. Falkenburger, T. Shimohata, K. Kunieda, J. Kassubek, R. Kassubek, MJ. Marti, G. Wenning, A. Fanciulli, C. Pototschnig, T. Gurevich, Y. Manor, HJ. Kim, D. Weise, P. Urban, R. Dziewas, T. Warnecke (Beelitz-Heilstätten, Germany)

    Objective: To investigate the prevalence of laryngeal motion abnormalities in patients with atypical Parkinsonism. Background: Using a previously published FEES task-protocol[1-3], we identified irregular involuntary…
  • 2023 International Congress

    Initial 24-hours Levodopa Carbidopa Intestinal Gel initiation in advanced Parkinson’s disease

    J. Szász, V. Constantin, K. Orban-Kiss, S. Bataga, L. Bancu, R. Neagoe, J. Szederjesi, M. Ciorba, I. Mihaly, K. Kelemen, S. Szatmari (TARGU MURES, Romania)

    Objective: To evaluate the profile of those patients with advanced Parkinson’s Disease (APD) in which we decided to use continuous 24-hour administration of Levodopa Carbidopa…
  • 2023 International Congress

    Plasma biomarkers in iRBD patients serve as potential markers of early PD and motor severity

    B. Huxford, C. Simonet-Hernandez, L. Pérez-Carbonell, A. Schrag, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: We aimed  to investigate biomarkers of inflammation and neuroaxonal damage in people with isolated REM sleep behaviour disorder (iRBD) compared to controls, and understand…
  • 2023 International Congress

    A 10-year service evaluation of a Cervical Dystonia Botulinum Toxin A Clinic: Factors associated with a patient satisfaction.

    M. Bradley, M. Ryan, F. Molloy (Dublin, Ireland)

    Objective: To review the factors associated with patient satisfaction of routine care with BoNT-A injections for CD in a “real world” clinical setting. Background: Cervical…
  • 2023 International Congress

    Patients activation in people with Parkinson disease and its relation to personal factors

    B. Naamneh Abuelhija, M. Kafri, M. Kestenbaum, S. Giveon, G. Yogev-Seligmann (Haifa, Israel)

    Objective: To identify individual factors associated with patient activation among people with Parkinson’s disease (PD). Background: The concept of patient activation captures subjective aspects of…
  • 2023 International Congress

    Tremor in patients with chronic inflammatory demyelinating polyneuropathy: prevalence and severity

    G. Pallada, SEM. Ten Holter, F. Eftimov, RMA. de Bie, AF. van Rootselaar, JM. Dijk (Amsterdam, Netherlands)

    Objective: To determine prevalence and severity of tremor in patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). Background: Tremor is an underrecognized and possibly disabling symptom…
  • 2023 International Congress

    motor and non-motor correlates of hyposmia detected by the italian olfactory identification test (ioit) in an italian cohort of parkinson’s disease patients

    A. Mechelli, N. Tambasco, M. Filidei, C. Maremmani, M. Pierini, P. Nigro, S. Simoni, L. Parnetti (Catanzaro, Italy)

    Objective: To characterize olfaction in a cohort of PD patients and to investigate the relationship between olfactory impairment with both motor and non-motor features and other clinical characteristics…
  • 2023 International Congress

    Cortical excitability of sensorimotor cortex in Parkinson’s disease-related pain

    MK. Lu, CM. Chen, SM. Liu, CH. Tsai (Taichung, Taiwan)

    Objective: To clarify the functional role of sensorimotor cortex in Parkinson’s disease (PD)-related pain. Background: Pain is one of the most common nonmotor symptoms in…
  • 2023 International Congress

    Primary CNS Lymphoma presenting with Hemichorea Hemiballismus.

    N. Sharma (Chandigarh, India)

    Objective: Completing the list of Hemichorea Hemiballismus apart from stroke and hyperglycaemic states. Background: 61years old female presented with subacute onset abnormal irregular purposeless movements…
  • 2023 International Congress

    Lysosomal-driven reduction of alpha-synuclein aggregates in a neuron-like model of Parkinson’s disease

    S. Lucas-Del-Pozo, G. Uras, F. Fierli, AHV. Schapira (London, United Kingdom)

    Objective: To test whether PIKfyve inhibition results in a lysosomal-driven reduction of alpha-synuclein aggregates in a mutant neuroblastoma cell line overexpressing an aggregation-prone form of…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley